Financhill
Back

WAVE Life Sciences Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
76

WVE
WAVE Life Sciences

Last Price:
13.89
Seasonality Move:
-7.21%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

WAVE Life Sciences Price Quote

$13.89
+0.05 (+0.73%)
(Updated: November 6, 2024 at 4:14 AM ET)

WAVE Life Sciences Key Stats

Buy
76
WAVE Life Sciences (WVE) is a Buy

Day range:
$13.42 - $13.91
52-week range:
$3.50 - $15.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.92
P/B ratio:
0%

Volume:
1M
Avg. volume:
2.4M
1-year change:
145.39%
Market cap:
$1.7B
Revenue:
$113.3M
EPS:
$-0.57

How Much Does WAVE Life Sciences Make?

Is WAVE Life Sciences Growing As A Company?

  • What Is WAVE Life Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.11%
  • What Is WAVE Life Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

WAVE Life Sciences Stock Price Performance

What Is WAVE Life Sciences 52-Week High & Low?

WAVE Life Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy WAVE Life Sciences?

Is WAVE Life Sciences Cash Flow Positive?

  • What Is WVE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$128.6M
  • What Is WAVE Life Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $110.8M
  • What Is WAVE Life Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1M

WAVE Life Sciences Return On Invested Capital

Data Unavailable

WAVE Life Sciences Earnings Date & Stock Price

WAVE Life Sciences Competitors

  • Who Are WAVE Life Sciences's Competitors?
    Below is a list of companies who compete with WAVE Life Sciences or are related in some way:
    • EUDA Health Holdings Ltd (EUDA)
    • CytoMed Therapeutics Ltd (GDTC)
    • Haw Par Corp Ltd (HAWPF)
    • Mobile-health Network Solutions (MNDR)
    • Raffles Medical Group Ltd (RAFLF)

WAVE Life Sciences Dividend Yield

WAVE Life Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -13.64%
Revenue: -10.92% 1.23%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 19.80
Upside from Last Price: 43.06%

Major Shareholders

  • How many WVE shares are owned by institutional investors?
    164.1M WVE shares are owned by institutional investors
  • How many WVE shares are owned by insiders?
    6.7M WVE shares are owned by insiders